Improved Accessibility to the Renal Transplant List

Summary

In 2014, the "States General of Kidney" have allowed to assess the situation concerning the management of chronic kidney disease on the national territory. Ex-Languedoc-Roussillon has emerged as one of the French regions with a high dialysis / transplant ratio compared to other regions. Disparities in accessibility to the kidney transplant list were also very important. In the ex-Languedoc-Roussillon Region, the number of patients on the renal transplant list was lower than the national average (18.9 vs. 24.1%, respectively, according to the REIN 2015 report).

In 2015, the Regional Health Agency (ARS) ex-Languedoc-Roussillon, has published proposals to improve the healthcare of the patient in chronic end stage renal failure, and accessibility to the national waiting list for renal transplantation (CRISTAL).

To increase accessibility to the national waiting list for renal transplantation by improving the patient's healthcare, our project is based on the creation of a reinforced exchanges connexion between the hospital's nephrology services professionals, dialysis units and liberal nephrologists. This will include having regular meetings between dialysis nephrologists and CHU nephrologists. The proposals for this project were:

1. to organize multidisciplinary consultation meetings between transplant and dialysis professionals
2. to set up an exchange platform and communication tools built on the model of telemedicine (COVOTEM), common to the nephrology departments of the University Hospital Center, dialysis units.

This new device for the management of chronic end stage renal failure should increase the number of patients on the national renal transplantation waiting list. It should also make it possible to reduce the time between: firstly, the sending of the pre-registration file to the transplantation at Montpellier University Hospital and registration, and secondly between dialysis and registration.on waiting list.

The investigators hope that this experiment will increase the number of registrations on the National Kidney Transplantation Waitlist (CRISTAL). The implementation of this innovative tool should facilitate communication between nephrologists dialysis centers and nephrologists of CHU Montpellier, and accelerate the process of registration on the National Kidney Transplantation Waitlist.

If this platform proves to be easy to use and if the project's evaluation criteria show significant results, the platform could then be used to monitor patients in post-transplantation. Indeed, the data of patients who perform an alternating follow-up would be available for the referring nephrologists and for the transplant center. The further development of the platform would allow to create a mode of communication via this platform.

Conditions

• Chronic End Stage Renal Failure

Sponsors & Collaborators

• Aider Montpellier : Dr Chalabi Lofti

  collaborator UNKNOWN

• Aider Cèvennes et Confins Rhodaniens : Dr Mohajer Médérick

  collaborator UNKNOWN

• Aider Nîmes : Philippe LAN YUE WAH

  collaborator UNKNOWN

• Aider Lozère : Dr Hélène LERAY / Dr Cécile TURC-BARON

  collaborator UNKNOWN

• Aider Perpignan : Dr Ahmed RACHI

  collaborator UNKNOWN

• CHU de Nîmes : Pr Moranne Olivier

  collaborator UNKNOWN

• CH de Perpignan : Dr Vela Carlos

  collaborator UNKNOWN

• Centre d'Hémodialyse St Guilhem : Dr Argilès Angèl

  collaborator UNKNOWN

• Clinique Médipôle Perpignan : Dr DECOURT Alexandre

  collaborator UNKNOWN

• Clinique de Narbonne : Dr De Cornélissen François

  collaborator UNKNOWN

• GCS Help : Dr Maria Eugenia Noguera Gonzales

  collaborator UNKNOWN

• NephroCare Castelnau / Mas du Rochet / Lunel : Dr Basel Olivia

  collaborator UNKNOWN

• NephroCare Béziers : Dr Baron Emmanuel

  collaborator UNKNOWN

• NephroCare Nîmes / Bagnols : Dr Rousseau Philippe

  collaborator UNKNOWN

• Villeneuve les Béziers : Dr Baron Emmanuel

  collaborator UNKNOWN

• GCS eSanté : Sylvain Collet

  collaborator UNKNOWN

• University Hospital, Montpellier

  lead OTHER

Principal Investigators

• Sylvie DELMAS, Doctor · University Hospital, Montpellier

Eligibility

Min Age

18 Years

Max Age

90 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-09-01

Primary Completion

2020-11-30

Completion

2020-12-30

Countries

• France

Study Locations